Premature Menopause Raises Heart Disease Risk, and Insulin Resistance May Be Part of the Reason
A 21-year study of 4,700 women links menopause before age 40 to higher insulin levels and more coronary heart disease. Insulin resistance may be a key pathway.
Resumen
Menopause before age 40, called premature menopause, affects about 1% of women and is tied to higher long-term health risks, including heart disease. A new study of more than 4,700 postmenopausal women aged 45 to 64 asked why. Over an average of 21.4 years of follow-up, researchers recorded 1,570 cardiovascular events. Women with premature menopause had a higher risk of cardiovascular disease and coronary heart disease than women who went through menopause at 45 or later. They did not have a higher risk of stroke or heart failure. They also had fasting insulin levels 9.3% higher, with no difference in fasting glucose. The findings suggest insulin resistance may be one biological pathway linking early estrogen loss to heart disease. Women with early menopause, between ages 40 and 44, showed no added risk. The work will be presented at The Menopause Society's 2026 Annual Meeting, so it has not yet been fully peer reviewed.
Resumen detallado
Premature menopause, defined as the end of menstrual function before age 40, affects roughly 1% of women. Because these women lose estrogen earlier, they spend more years postmenopausal and face higher risks of cardiovascular disease and osteoporosis. Why the heart risk rises has been unclear, and answering that could point to ways to prevent it.
A new analysis drew on more than 4,700 postmenopausal women, aged 45 to 64 at the start, from the ARIC cohort. Over a mean follow-up of 21.4 years, 1,570 cardiovascular events occurred. Compared with women whose menopause came at 45 or later, women with premature menopause had greater risks of overall cardiovascular disease and incident coronary heart disease. Risks of stroke and heart failure were not significantly higher. Women with early menopause, between 40 and 44, showed no added risk for any of these outcomes.
The researchers then looked at cardiometabolic markers that might explain the link. Premature menopause was associated with fasting insulin levels 9.3% higher, while fasting glucose did not differ. This pattern is typical of insulin resistance, in which the body compensates for reduced insulin sensitivity by producing more insulin while keeping glucose normal. The study's mediation analysis suggests insulin resistance may account for part of the added cardiovascular risk. That fits the broader view that estrogen helps regulate metabolic and vascular health.
For practice, the findings highlight the value of cardiometabolic monitoring in women who go through menopause before 40. Fasting insulin, waist circumference, lipids and blood pressure may catch problems that glucose alone misses. Lifestyle measures that improve insulin sensitivity, such as resistance and aerobic exercise, weight management and diet quality, are reasonable priorities. Clinicians may also consider individualized decisions about hormone therapy.
Several caveats apply. The results come from a conference presentation summarized in a press release, not a full peer-reviewed paper. Observational data cannot prove causation, and insulin resistance appears to explain only part of the risk. Menopause age was likely self-reported, and the number of premature cases is small.
Hallazgos clave
- Premature menopause (before 40) was linked to higher risks of cardiovascular disease and coronary heart disease over 21.4 years.
- Women with premature menopause had fasting insulin 9.3% higher, but fasting glucose was unchanged.
- Insulin resistance may partly explain the heart risk tied to menopause before age 40.
- Early menopause (ages 40-44) showed no significantly greater cardiovascular risk than menopause at 45 or later.
- Stroke and heart failure risks were not significantly higher with premature menopause.
Metodología
This is a press release on a conference presentation, based on a prospective cohort analysis (ARIC) of more than 4,700 women with mediation analysis. The source is a reputable professional society, but the data are not yet peer reviewed.
Limitaciones del estudio
Only a press summary is available, with no effect sizes, confidence intervals or the extent of mediation reported. Observational design limits causal claims, and premature menopause cases are few and likely self-reported. Check the full abstract or paper for adjustments and statistics.
¿Te ha gustado este resumen?
Recibe la última investigación sobre longevidad en tu bandeja de entrada cada semana.
Introduce tu correo electrónico para suscribirte:
